These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

476 related articles for article (PubMed ID: 35392088)

  • 21. Remodeling cancer stemness by collagen/fibronectin
    Zhong C; Tao B; Tang F; Yang X; Peng T; You J; Xia K; Xia X; Chen L; Peng L
    Theranostics; 2021; 11(4):1991-2005. PubMed ID: 33408794
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enhanced cytotoxic effect of radiation and temozolomide in malignant glioma cells: targeting PI3K-AKT-mTOR signaling, HSP90 and histone deacetylases.
    Choi EJ; Cho BJ; Lee DJ; Hwang YH; Chun SH; Kim HH; Kim IA
    BMC Cancer; 2014 Jan; 14():17. PubMed ID: 24418474
    [TBL] [Abstract][Full Text] [Related]  

  • 23. E2F2 drives glioma progression via PI3K/AKT in a PFKFB4-dependent manner.
    Zhang L; Liu Z; Dong Y; Kong L
    Life Sci; 2021 Jul; 276():119412. PubMed ID: 33774025
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Schisandrin B suppresses glioma cell metastasis mediated by inhibition of mTOR/MMP-9 signal pathway.
    Jiang Y; Zhang Q; Bao J; Du C; Wang J; Tong Q; Liu C
    Biomed Pharmacother; 2015 Aug; 74():77-82. PubMed ID: 26349966
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Targeting PI3K/AKT/mTOR-mediated autophagy for tumor therapy.
    Xu Z; Han X; Ou D; Liu T; Li Z; Jiang G; Liu J; Zhang J
    Appl Microbiol Biotechnol; 2020 Jan; 104(2):575-587. PubMed ID: 31832711
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The atypical protein kinase RIOK3 contributes to glioma cell proliferation/survival, migration/invasion and the AKT/mTOR signaling pathway.
    Zhang T; Ji D; Wang P; Liang D; Jin L; Shi H; Liu X; Meng Q; Yu R; Gao S
    Cancer Lett; 2018 Feb; 415():151-163. PubMed ID: 29233656
    [TBL] [Abstract][Full Text] [Related]  

  • 27. NVP-BEZ235, a novel dual PI3K-mTOR inhibitor displays anti-glioma activity and reduces chemoresistance to temozolomide in human glioma cells.
    Yu Z; Xie G; Zhou G; Cheng Y; Zhang G; Yao G; Chen Y; Li Y; Zhao G
    Cancer Lett; 2015 Oct; 367(1):58-68. PubMed ID: 26188279
    [TBL] [Abstract][Full Text] [Related]  

  • 28. miR-489 inhibits proliferation, cell cycle progression and induces apoptosis of glioma cells via targeting SPIN1-mediated PI3K/AKT pathway.
    Li Y; Ma X; Wang Y; Li G
    Biomed Pharmacother; 2017 Sep; 93():435-443. PubMed ID: 28666210
    [TBL] [Abstract][Full Text] [Related]  

  • 29. M2 macrophage-derived exosomal microRNAs inhibit cell migration and invasion in gliomas through PI3K/AKT/mTOR signaling pathway.
    Yao J; Wang Z; Cheng Y; Ma C; Zhong Y; Xiao Y; Gao X; Li Z
    J Transl Med; 2021 Mar; 19(1):99. PubMed ID: 33676540
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Estrogen receptor β agonist enhances temozolomide sensitivity of glioma cells by inhibiting PI3K/AKT/mTOR pathway.
    Liu X; Wang L; Chen J; Ling Q; Wang H; Li S; Li L; Yang S; Xia M; Jing L
    Mol Med Rep; 2015 Feb; 11(2):1516-22. PubMed ID: 25351348
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Arbutin exerts anticancer activity against rat C6 glioma cells by inducing apoptosis and inhibiting the inflammatory markers and P13/Akt/mTOR cascade.
    Yang Z; Shi H; Chinnathambi A; Salmen SH; Alharbi SA; Veeraraghavan VP; Surapaneni KM; Arulselvan P
    J Biochem Mol Toxicol; 2021 Sep; 35(9):e22857. PubMed ID: 34338399
    [TBL] [Abstract][Full Text] [Related]  

  • 32. RIP1 activates PI3K-Akt via a dual mechanism involving NF-kappaB-mediated inhibition of the mTOR-S6K-IRS1 negative feedback loop and down-regulation of PTEN.
    Park S; Zhao D; Hatanpaa KJ; Mickey BE; Saha D; Boothman DA; Story MD; Wong ET; Burma S; Georgescu MM; Rangnekar VM; Chauncey SS; Habib AA
    Cancer Res; 2009 May; 69(10):4107-11. PubMed ID: 19435890
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anticancer effects of veratramine via the phosphatidylinositol-3-kinase/serine-threonine kinase/mechanistic target of rapamycin and its downstream signaling pathways in human glioblastoma cell lines.
    Kim D; Kwon W; Park S; Kim W; Park JK; Han JE; Cho GJ; Yun S; Han SH; Kim MO; Ryoo ZY; Choi SK
    Life Sci; 2022 Jan; 288():120170. PubMed ID: 34826438
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Elevated PDK1 Expression Drives PI3K/AKT/MTOR Signaling Promotes Radiation-Resistant and Dedifferentiated Phenotype of Hepatocellular Carcinoma.
    Bamodu OA; Chang HL; Ong JR; Lee WH; Yeh CT; Tsai JT
    Cells; 2020 Mar; 9(3):. PubMed ID: 32197467
    [TBL] [Abstract][Full Text] [Related]  

  • 35. miR-93 promotes cell proliferation in gliomas through activation of PI3K/Akt signaling pathway.
    Jiang L; Wang C; Lei F; Zhang L; Zhang X; Liu A; Wu G; Zhu J; Song L
    Oncotarget; 2015 Apr; 6(10):8286-99. PubMed ID: 25823655
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mahanine induces apoptosis, cell cycle arrest, inhibition of cell migration, invasion and PI3K/AKT/mTOR signalling pathway in glioma cells and inhibits tumor growth in vivo.
    Chen M; Yin X; Lu C; Chen X; Ba H; Cai J; Sun J
    Chem Biol Interact; 2019 Feb; 299():1-7. PubMed ID: 30468732
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Akt-mTOR signaling is involved in Notch-1-mediated glioma cell survival and proliferation.
    Zhao N; Guo Y; Zhang M; Lin L; Zheng Z
    Oncol Rep; 2010 May; 23(5):1443-7. PubMed ID: 20372862
    [TBL] [Abstract][Full Text] [Related]  

  • 38. KIAA0101 knockdown inhibits glioma progression and glycolysis by inactivating the PI3K/AKT/mTOR pathway.
    Wang K; Li J; Zhou B
    Metab Brain Dis; 2022 Feb; 37(2):489-499. PubMed ID: 34792707
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epithelial membrane protein 1 promotes glioblastoma progression through the PI3K/AKT/mTOR signaling pathway.
    Miao L; Jiang Z; Wang J; Yang N; Qi Q; Zhou W; Feng Z; Li W; Zhang Q; Huang B; Chen A; Zhang D; Zhao P; Li X
    Oncol Rep; 2019 Aug; 42(2):605-614. PubMed ID: 31233190
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Complexity of Targeting PI3K-Akt-mTOR Signalling in Human Acute Myeloid Leukaemia: The Importance of Leukemic Cell Heterogeneity, Neighbouring Mesenchymal Stem Cells and Immunocompetent Cells.
    Brenner AK; Andersson Tvedt TH; Bruserud Ø
    Molecules; 2016 Nov; 21(11):. PubMed ID: 27845732
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.